Hoy W, Jim S, Warrington W, Light A, Megill D
Center for Health and Population Research, Lovelace Institutes, Albuquerque, NM.
Am J Kidney Dis. 1996 Sep;28(3):339-49. doi: 10.1016/s0272-6386(96)90490-4.
We screened a sample of adult Navajo Indians for signs of renal disease that might underlie their increasing rates of renal failure. Nondiabetics had modest rates of hypertension, which was more common in males and increased with age. Microscopic hematuria was very common, and only a fraction was associated with progressive nephropathy. Microalbuminuria, mostly undetected by routine dipstick, was present in 14.6% of subjects; overt albuminuria was present in 2%. Increasing albuminuria was related to renal insufficiency, which was more common in males. Hypertension was associated with greater then threefold increases in both albuminuria and renal insufficiency. Cardiovascular disease was uncommon and had no discernible relationship to albuminuria. Most diabetic patients (58.4%) had hypertension, with equal rates for males and females. Fully half of all diabetic patients had unsatisfactory blood pressure levels at screening. Rates and patterns of hematuria were like those of nondiabetics. Microalbuminuria was present in 36.1% and overt albuminuria in 17.9%, four and eight times the rates in matched nondiabetics, respectively; these differences persisted after controlling for blood pressure. Renal insufficiency was associated with progressive albuminuria and was present in 10.6%, with equal rates in males and females. Hypertension, albuminuria, and renal insufficiency, but not hematuria, increased with increasing diabetes duration. Hypertension was associated with a twofold increase in albuminuria, a threefold increase in overt albuminuria, and an eightfold increase in renal insufficiency. Cardiovascular disease had no detectable association with microalbuminuria, but had a strong relationship to overt albuminuria. The high rates of hematuria are not well explained. It probably has nonrenal as well as renal origins, the latter including mesangial proliferative glomerulonephritis. The impressive rates of albuminuria among diabetic patients mark a large reservoir of renal disease and fore-shadow even larger burdens of end-stage renal disease and cardiovascular disease in the near future. Improved detection and treatment of hypertension is needed to slow the progression of renal disease in nondiabetics and diabetics, together with screening and treatment protocols for albuminuric diabetic patients. Prevention of albuminuria probably involves population-based modification of blood pressure and metabolic profiles.
我们对一群成年纳瓦霍印第安人进行了筛查,以寻找可能是其肾衰竭发病率上升原因的肾脏疾病迹象。非糖尿病患者的高血压发病率适中,男性更为常见且随年龄增长而增加。镜下血尿非常常见,只有一小部分与进行性肾病有关。微量白蛋白尿大多无法通过常规试纸检测出来,14.6%的受试者存在微量白蛋白尿;显性白蛋白尿的比例为2%。白蛋白尿增加与肾功能不全有关,男性更为常见。高血压与白蛋白尿和肾功能不全增加三倍以上有关。心血管疾病并不常见,与白蛋白尿没有明显关系。大多数糖尿病患者(58.4%)患有高血压,男性和女性发病率相同。在筛查时,所有糖尿病患者中有一半的血压水平不理想。血尿的发生率和模式与非糖尿病患者相似。微量白蛋白尿的发生率为36.1%,显性白蛋白尿为17.9%,分别是非糖尿病对照组的四倍和八倍;在控制血压后,这些差异仍然存在。肾功能不全与进行性白蛋白尿有关,发生率为10.6%,男性和女性发病率相同。高血压、白蛋白尿和肾功能不全,但不包括血尿,会随着糖尿病病程的延长而增加。高血压与白蛋白尿增加两倍、显性白蛋白尿增加三倍以及肾功能不全增加八倍有关。心血管疾病与微量白蛋白尿没有可检测到的关联,但与显性白蛋白尿有很强的关系。血尿的高发生率难以得到很好的解释。它可能有非肾脏和肾脏来源,后者包括系膜增生性肾小球肾炎。糖尿病患者中令人印象深刻的白蛋白尿发生率标志着大量的肾脏疾病,预示着在不久的将来终末期肾病和心血管疾病的负担将更大。需要改进高血压的检测和治疗,以减缓非糖尿病患者和糖尿病患者肾脏疾病的进展,同时制定白蛋白尿糖尿病患者的筛查和治疗方案。预防白蛋白尿可能需要基于人群的血压和代谢状况调整。